Old Web
English
Sign In
Acemap
>
authorDetail
>
Carlos Silva-Rosas
Carlos Silva-Rosas
University of Chile
Internal medicine
Multiple sclerosis
Medicine
Disease
disease activity
4
Papers
8
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Clinical outcomes in patients with COVID-19 infection during phase IV studies of cladribine tablets for treatment of multiple sclerosis
2020
Multiple Sclerosis Journal
Carlos Guevara
Eduardo Villa
Marcela Cifuentes
Melissa Martinez
Cristián Garrido
Violeta Díaz
Carlos Silva-Rosas
Rodrigo Naves
J. de Grazia
Show All
Source
Cite
Save
Citations (0)
Inclusion of the Symbol Digit Modalities Test in a revised assessment of ‘no evidence of disease activity-4 (NEDA-4)’ in Latin-American patients with multiple sclerosis
2020
Multiple sclerosis and related disorders
Carlos Guevara
Eduardo Villa
Violeta Díaz
Cristián Garrido
Melissa Martinez
Patricia Orellana
Pablo Alarcón
Carlos Silva-Rosas
Gareth J. Barker
Matthew J. Kempton
Jose de Grazia
Show All
Source
Cite
Save
Citations (2)
Serial decline of no evidence of disease activity-4 status in early disease stages of multiple sclerosis
2019
Journal of the Neurological Sciences
Carlos Guevara
Melissa Martinez
Patricia Orellana
Carlos Silva-Rosas
Violeta Díaz
J. De Gazia
Cristián Garrido
Show All
Source
Cite
Save
Citations (0)
Encephalitis Associated to Metabotropic Glutamate Receptor 5 (mGluR5) Antibodies in Cerebrospinal Fluid
2018
Frontiers in Immunology
Carlos Guevara
Gonzalo A. Farías
Carlos Silva-Rosas
Pablo Alarcón
Gabriel Abudinen
Julio Espinoza
Andrés Caro
Heather Angus-Leppan
Jose de Grazia
Show All
Source
Cite
Save
Citations (6)
1